- US-listed companies
- Edesa Biotech, Inc.
- Balance sheet
Edesa Biotech, Inc.【EDSA】Balance sheet
Market cap
$35.96M
P/E ratio
| 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Cash and cash equivalents | 4 | 7 | 5 | 4 | 7 | 8 | 7 | 5 | 1 |
| Marketable securities, current | 5 | 4 | 2 | 6 | - | - | - | - | - |
| Total cash & short-term investments | 9 | 11 | 7 | 10 | 7 | 8 | 7 | 5 | 1 |
| Inventories | 557,280 | 249,430 | 68,114 | 224,267 | - | - | - | - | - |
| Total current assets | 10 | 12 | 7 | 11 | 8 | 12 | 9 | 6 | 2 |
| Property, plant and equipment, net | 503,408 | 756,114 | 879,523 | 1 | 14,815 | 14,989 | 12,694 | 8,702 | - |
| Total non-current assets | 519,308 | 838,149 | 961,558 | 1 | 3 | 2 | 2 | 2 | 2 |
| Total assets | 10 | 13 | 8 | 12 | 11 | 15 | 12 | 9 | 4 |
| Total current liabilities | 2 | 623,644 | 320,947 | 493,385 | 2 | 1 | 2 | 2 | 2 |
| Total non-current liabilities | - | - | - | - | 124,388 | 67,714 | 43,662 | 19,773 | - |
| Total liabilities | 2 | - | - | - | 2 | 2 | 2 | 2 | 2 |
| Common stock and paid-in capital | 38 | 47 | 48 | 57 | 20 | 40 | 54 | 60 | 61 |
| Retained earnings | -35,335,315 | -40,361,395 | -45,392,043 | -50,430,992 | -13,132,954 | -26,495,629 | -44,044,553 | -52,418,968 | -59 |
| Stockholders' equity | 8 | 12 | 7 | 11 | 7 | 13 | 9 | 7 | 2 |